Myocardial β2-adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure

British Journal of Pharmacology

Volumn 166, Issue 8, 2012, Pages 2348-2361

  Rengo, G ^a,b,c   Zincarelli, C ^a,b,c   Femminella, G D ^b   Liccardo, D ^b   Pagano, G ^b   De Lucia, C ^b   Altobelli, G G ^b   Cimini, V ^b   Ruggiero, D ^b   Perrone Filardi, P ^b   Gao, E ^c   Ferrara, N ^a   Lymperopoulos, A ^d   Koch, W J ^c   Leosco, D ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

angiogenesis; gene therapy; heart failure; remodelling

Indexed keywords

ADENOVIRUS VECTOR; BETA 2 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BETA 2 ADRENERGIC RECEPTOR GENE; CAPILLARY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GENE EXPRESSION; GENE OVEREXPRESSION; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE REMODELING; HEART MUSCLE CAPILLARY; HEART MUSCLE CONTRACTILITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TRANSGENE; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 84864435906     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01954.x     Document Type: Article

References (47)

1. Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI, (2004). Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 110: 1083-1090. (Pubitemid 39319006)
2. Anversa P, Beghi C, Kikkawa Y, Olivetti G, (1986). Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 58: 26-37. (Pubitemid 16165930)
3. Bernstein D, Fajardo G, Zhao M, Urashima T, Powers J, Berry G, et al,. (2005). Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol 289: H2441-H2449. (Pubitemid 41698555)
4. Brinks H, Boucher M, Gao E, Chuprun JK, Pesant S, Raake PW, et al,. (2010). Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Circ Res 107: 1140-1149.
5. Ciccarelli M, Sorriento D, Cipolletta E, Santulli G, Fusco A, Zhou RH, et al,. (2011). Impaired neoangiogenesis in β2-adrenoceptor gene-deficient mice: restoration by intravascular human β2-adrenoceptor gene transfer and role of NFΰB and CREB transcription factors. Br J Pharmacol 162: 712-721.
6. 2adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100: 2210-2212.
7. 2adrenergic receptors differentially affects cardiac hypertrophy and function in Gaq overexpressing mice. Proc Natl Acad Sci U S A 96: 6400-6405. (Pubitemid 29256677)
8. Feldman DS, Carnes CA, Abraham WT, Bristow MR, (2005). Mechanisms of disease: beta-adrenergic receptors-alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med 2: 475-483. (Pubitemid 41223525)
9. 2adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 97: 1182-1189.
10. Karam R, Healy BP, Wicker P, (1990). Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation 81: 238-246. (Pubitemid 20031788)
11. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010) NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
12. Lands AM, Arnold A, Mcauliff JP, Luduena FP, Brown TG, (1967). Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 596-598.
13. Lefkowitz RJ, (1993). G protein-coupled receptor kinases. Cell 74: 409-412. (Pubitemid 23244606)
14. Leosco D, Rengo G, Iaccarino G, Filippelli A, Lymperopoulos A, Zincarelli C, et al,. (2007). Exercise training and β-blocker treatment ameliorate age-dependent impairment of β-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation. Am J Physiol Heart Circ Physiol 293: H1596-H1603. (Pubitemid 47367205)
15. Leosco D, Rengo G, Iaccarino G, Golino L, Marchese M, Fortunato F, et al,. (2008). Exercise promotes angiogenesis and improves beta-adrenergic receptor signaling in the post-ischaemic failing rat heart. Cardiovasc Res 78: 385-394. (Pubitemid 351556096)
16. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, et al,. (2000). Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101: 1707-1714. (Pubitemid 30196632)
17. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC, (2005). A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 11: 952-958. (Pubitemid 41294440)
18. Lohse MJ, Engelhardt S, Eschenhagen T, (2003). What is the role of beta-adrenergic signaling in heart failure? Circ Res 93: 896-906. (Pubitemid 37433227)
19. Lymperopoulos A, Rengo G, Koch WJ, (2007a). Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation. Trends Mol Med 13: 503-511. (Pubitemid 350123195)
20. Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ, (2007b). Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13: 315-323. (Pubitemid 46376685)
21. Lymperopoulos A, Rengo G, Zincarelli C, Soltys S, Koch WJ, (2008). Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of g protein-coupled receptor kinase-2 activity. Mol Ther 16: 302-307. (Pubitemid 351168039)
22. Lymperopoulos A, Rengo G, Zincarelli C, Kim J, Soltys S, Koch WJ, (2009). An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo. Proc Natl Acad Sci U S A 106: 5825-5830.
23. Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW 2nd, Koch WJ, (2010). Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem 285: 16378-16386.
24. Mann DL, Bristow MR, (2005). Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111: 2837-2849. (Pubitemid 40791557)
25. 2adrenergic receptor gene delivery. J Clin Invest 104: 21-29. (Pubitemid 29534341)
26. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
27. 2adrenergic receptor. Science 264: 582-586.
28. Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, Sadoshima J, (2000). The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem 275: 14466-14475. (Pubitemid 30339733)
29. Rengo F, Losco D, Iacovoni A, Rengo G, Golino L, Borgia F, et al,. (2004). Epidemiologia clinica e fattori di rischio per lo scompenso nell'anziano. Ital Heart J 5: 3S-10S.
30. Rengo G, Lymperopoulos A, Zincarelli C, Donniacuo M, Soltys S, Rabinowitz JE, et al,. (2009). Myocardial adeno-associated virus serotype 6-βARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 119: 89-98.
31. Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G, Liccardo D, et al,. (2010). Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am J Physiol Heart Circ Physiol 298: H2032-H2038.
32. Rengo G, Lymperopoulos A, Leosco D, Koch WJ, (2011). GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol 50: 785-792.
33. Rockman HA, Koch WJ, Lefkowitz RJ, (2002). Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212. (Pubitemid 34059526)
34. Rohrer DK, Chruscinski A, Schauble EH, Bernstein D, Kobilka BK, (1999). Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J Biol Chem 274: 16701-16708.
35. Shiojima I, Walsh K, (2006). Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20: 3347-3365. (Pubitemid 44969154)
36. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al,. (2005). Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118. (Pubitemid 41134152)
37. 2adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 106: 124-129. (Pubitemid 34747452)
38. Tong H, Bernstein D, Murphy E, Steenbergen C, (2005). The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 19: 983-985. (Pubitemid 40827725)
39. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J, (2009). The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54: 1747-1762.
40. 1adrenergic receptors in the failing heart. Circulation 87: 454-463. (Pubitemid 23040915)
41. Ungerer M, Parruti G, Böhm M, Puzicha M, DeBlasi A, Erdmann E, et al,. (1994). Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 74: 206-213.
42. Xiao RP, Zhu W, Zheng M, Bond R, Lakatta EG, Cheng H, (2004). Subtypespecific β-adrenergic signaling pathways and their clinical implications. Trends Pharmacol Sci 25: 358-365. (Pubitemid 38829489)
43. Xydas S, Kherani AR, Chang JS, Klotz S, Hay I, Mutrie CJ, et al,. (2006). Beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther 317: 553-561.
44. Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MA, (2000). β-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102: 344-350. (Pubitemid 30457587)
45. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP, (2001). Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A 98: 1607-1612. (Pubitemid 32165546)
46. 2Adrenergic Receptor Gi Signaling in the Heart. The Good, the Bad, and the Ugly. Circ Res 97: 507-509. (Pubitemid 41361739)
47. Zincarelli C, Soltys S, Rengo G, Koch WJ, Rabinowitz JE, (2010). Comparative Cardiac Gene Delivery of Adeno-Associated Virus Serotypes 1-9 reveals that AAV6 Mediates the Most Efficient Transduction in Mouse Heart. Clin Transl Sci 3: 81-89.